Hoogeveen Irene J, van der Ende Rixt M, van Spronsen Francjan J, de Boer Foekje, Heiner-Fokkema M Rebecca, Derks Terry G J
Section of Metabolic Diseases, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, 30 001, 9700 RB, Groningen, The Netherlands.
Laboratory of Metabolic Diseases, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
JIMD Rep. 2016;28:41-47. doi: 10.1007/8904_2015_511. Epub 2015 Nov 3.
According to the textbooks, the ketotic glycogen storage disease (GSD) types 0, III, VI, IX, and XI are associated with fasting ketotic hypoglycemia and considered milder as gluconeogenesis is intact.
A retrospective cohort study of biochemical profiles from supervised clinical fasting studies is performed in ketotic GSD patients in our metabolic center. For data analysis, hypoglycemia was defined as plasma glucose concentration <2.6 mmol/L. Total KB was defined as the sum of blood acetoacetate and β-hydroxybutyrate concentrations. If the product of glucose and KB concentrations was greater than 10, a ketolysis defect was suspected.
Data could be collected from 13 fasting studies in 12 patients with GSD III (n = 4), GSD VI (n = 3), and GSD IX (n = 5). Six patients remained normoglycemic with median glucose concentration of 3.9 mmol/L (range, 2.8-4.6 mmol/L) and median total KB concentration of 1.9 mmol/L (range, 0.6-5.1 mmol/L). The normoglycemic patients included type VI (3 out of 3) and type IX (3 out of 5) patients. All type III patients developed ketotic hypoglycemia. Interestingly, in five patients (one GSD III, one GSD VI, and three GSD IX), the biochemical profile suggested a ketolysis defect.
Normoglycemic ketonemia is a common biochemical presentation in patients with GSD types VI and IX, and ketonemia can precede hypoglycemia in all studied GSD types. Therefore, GSD VI and GSD IX should be added to the differential diagnosis of ketotic normoglycemia, and KB concentrations should be routinely measured in ketotic GSD patients.
根据教科书,0型、III型、VI型、IX型和XI型酮症性糖原贮积病(GSD)与空腹酮症性低血糖相关,且由于糖异生功能完好,被认为病情较轻。
对我们代谢中心的酮症性GSD患者进行了一项基于监督性临床空腹研究生化指标的回顾性队列研究。数据分析时,低血糖定义为血浆葡萄糖浓度<2.6 mmol/L。总酮体(KB)定义为血中乙酰乙酸和β-羟基丁酸浓度之和。如果葡萄糖和KB浓度的乘积大于10,则怀疑存在酮体分解缺陷。
可从12例患者的13项空腹研究中收集数据,这些患者包括III型GSD(n = 4)、VI型GSD(n = 3)和IX型GSD(n = 5)。6例患者血糖正常,葡萄糖浓度中位数为3.9 mmol/L(范围2.8 - 4.6 mmol/L),总KB浓度中位数为1.9 mmol/L(范围0.6 - 5.1 mmol/L)。血糖正常的患者包括VI型(3/3)和IX型(3/5)患者。所有III型患者均出现酮症性低血糖。有趣的是,5例患者(1例III型GSD、1例VI型GSD和3例IX型GSD)的生化指标提示存在酮体分解缺陷。
血糖正常性酮血症是VI型和IX型GSD患者常见的生化表现,并且在所有研究的GSD类型中,酮血症可先于低血糖出现。因此,VI型和IX型GSD应纳入酮症性血糖正常的鉴别诊断,并且应常规检测酮症性GSD患者的KB浓度。